| Updated:
Glaxo in emerging market deal
GlaxoSmithKline took another significant step in building its business in emerging markets yesterday by signing an alliance with Indian generic drugmaker Dr Reddy’s Laboratories. The move builds on a deal last week with China’s Shenzhen Neptunus for flu vaccines.